3rd Quarter - Report
THE UNITED STATES PHARMACOPEIAL CONVENTION for THE UNITED STATES PHARMACOPEIAL CONVENTION
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 6, SUPPORT for Patients and Communities Act; provisions related to opioids. Potential role of compendial standards for packaging
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.